Company / Cost of Revenue
LivaNova Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$448.2M
FY2025
5-year range
$339.5M / $448.2M
FY2021-FY2025
Trend
+12.1%
vs FY2024
Sector context
#66 of 113
Health Care
What the data says
At $448M, LivaNova's cost of revenue ranks #48 of 113 in the Health Care sector. Cost of Revenue has increased for 3 consecutive years, from $339M in FY2022 to $448M in FY2025.
Based on SEC 10-K filings.
$448M in FY2025 with a 5-year CAGR of +5.7%.
Increased from $398M to $448M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +9.7%
- 5-Year CAGR
- +5.7%
- 10-Year CAGR
- -
Sector benchmark
#48 of 113 in Health CareTop 42% of 113This company $448.2M Sector average $11.3B
▼
-96.0% below sector average
Key checks
Key Insights
- LivaNova's cost of revenue has grown for 3 consecutive years.
- 5-year CAGR of +5.7%, indicating consistent growth.
- In FY2025, cost of revenue increased 12.1% year-over-year.
- Ranks #66 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $448.2M | +12.1% |
| FY2024 | $400.0M | +0.6% |
| FY2023 | $397.7M | +17.2% |
| FY2022 | $339.5M | -5.8% |
| FY2021 | $360.4M | +6.2% |
| FY2020 | $339.5M | -5.8% |
| FY2019 | $360.4M | -0.3% |
| FY2018 | $361.3M | +2.3% |
| FY2017 | $353.2M | -4.0% |
| FY2016 | $367.8M | +224.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026